Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search
  1. NCI-F Publications

Search
  1. Year Published:

Your search returned 134 results.
User Information
Export Records
  1. 1.   Second-generation checkpoint inhibitors and Treg depletion synergize with a mouse cancer vaccine in accordance with tumor microenvironment characterization
  2. Becker, William; Olkhanud, Purevdorj B; Seishima, Noriko; Moreno, Paloma A; Goldfarbmuren,Kate; Maeng, Hoyoung M; Berzofsky, Jay A
  3. Journal for Immunotherapy of Cancer. 2024, Jul 01; 12(7):
  1. 2.   Near-infrared duocarmycin photorelease from a Treg-targeted antibody-drug conjugate improves efficacy of PD-1 blockade in syngeneic murine tumor models
  2. Fukushima, Hiroshi; Furusawa, Aki; Takao, Seiichiro; Thankarajan Mini Mablet,Ebaston; Luciano, Michael P; Usama, Syed Muhammad; Kano, Makoto; Okuyama, Shuhei; Yamamoto, Hiroshi; Suzuki, Motofumi; Kano, Miyu; Choyke, Peter L; Schnermann,Martin; Kobayashi, Hisataka
  3. Oncoimmunology. 2024, Jun 20; 13(1): 2370544.
  1. 3.   Functionally diverse thymic medullary epithelial cells interplay to direct central tolerance
  2. Ushio, Aya; Matsuda-Lennikov, Mami; Kalle-Youngoue,Felix; Shimizu, Akihide; Abdelmaksoud, Abdalla; Kelly, Michael C; Ishimaru, Naozumi; Takahama, Yousuke
  3. Cell Reports. 2024, Apr 05; 43(4): 114072.
  1. 4.   An engineered cell line with a hRpn1-attached handle to isolate proteasomes
  2. Negi,Hitendra; Osei Amponsa,Vasty; Ibrahim, Bishoy; Evans, Christine N; Sullenberger, Catherine; Loncarek,Jadranka; Chari,Raj; Walters,Kylie
  3. The Journal of Biological Chemistry. 2023, Jun 22; 104948.
  1. 5.   Anti-TNFR2 enhanced the antitumor activity of a new HMGN1/3M-052 stimulated dendritic cell vaccine in a mouse model of colon cancer
  2. Zhu, Lan; Zhang, Xiangyan; Chen, Xin; Yang,De; Nie, Yujie; Pan, Runsang; Li, Linzhao; Wang, Chenglv; Gui, Huan; Chen, Shuanghui; Jing, Qianyu; Wang, Mengjiao; Nie, Yingjie
  3. Biochemical and Biophysical Research Communications. 2023, Feb 16; 653: 106-114.
  1. 6.   A TNFR2 antibody by countering immunosuppression cooperates with HMGN1 and R848 immune stimulants to inhibit murine colon cancer
  2. Jiang, Mengmeng; Liu,Jia; Yang,De; Tross,Debra; Li, Ping; Chen, Fengyang; Alam,Md Masud; Faustman, Denise L; Oppenheim,Joost; Chen, Xin
  3. International immunopharmacology. 2021, Nov 15; 101(Pt A): 108345.
  1. 7.   Parallel and Population-specific Gene Regulatory Evolution in Cold-Adapted Fly Populations
  2. Huang, Yuheng; Lack,Justin; Hoppel, Grant T.; Pool, John E.
  3. Genetics. 2021, May 14; 218
  1. 8.   Impact of TCM on Tumor-Infiltrating Myeloid Precursors in the Tumor Microenvironment
  2. Liu, Jinlong; Wang, Yuchen; Qiu, Zhidong; Lv, Guangfu; Huang, Xiaowei; Lin, He; Lin, Zhe; Qu, Peng
  3. Frontiers in Cell and Developmental Biology. 2021, Mar 4; 9
  1. 10.   An Integrated Epigenomic and Transcriptomic Map of Mouse and Human aß T Cell Development
  2. Chopp, Laura B; Gopalan, Vishaka; Ciucci, Thomas; Ruchinskas,Allison; Rae, Zachary; Lagarde, Manon; Gao, Yayi; Li, Caiyi; Bosticardo, Marita; Pala, Francesca; Livak, Ferenc; Kelly,Michael; Hannenhalli, Sridhar; Bosselut, Rémy
  3. Immunity. 2020, Dec 15; 53(6): 1182-1201.e8.
  1. 11.   Type I IFN signaling in T regulatory cells modulates chemokine production and myeloid derived suppressor cells trafficking during EAE
  2. Tanwar, Shalini; Oguz,Cihan; Metidji, Amina; Dahlstrom, Eric; Barbian, Kent; Kanakabandi, Kishore; Sykora, Lydia; Shevach, Ethan M
  3. Journal of autoimmunity. 2020, DEC; 115: 102525.
  1. 12.   Structural Features that Distinguish Inactive and Active PI3K Lipid Kinases
  2. Zhang,Mingzhen; Jang,Hyunbum; Nussinov,Ruth
  3. Journal of molecular biology. 2020, NOV 6; 432(22): 5849-5859.
  1. 13.   The Regulatory Role of MicroRNA in Hepatitis-B Virus-Associated Hepatocellular Carcinoma (HBV-HCC) Pathogenesis
  2. Sartorius, Kurt; Makarova, Julia; Sartorius, Benn; An,Ping; Winkler,Cheryl; Chuturgoon, Anil; Kramvis, Anna
  3. Cells. 2019, DEC; 8(12):
  1. 14.   Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
  2. Forero, Adriana; Ozarkar, Snehal; Li,Hongchuan; Lee, Chia Heng; Hemann, Emily A; Nadjsombati, Marija S; Hendricks, Matthew R; So, Lomon; Green, Richard; Roy, Chandra N; Sarkar, Saumendra N; von Moltke, Jakob; Anderson,Steve; Gale, Michael; Savan, Ram
  3. Immunity. 2019, SEP 17; 51(3): 451-+.
  1. 15.   Bridging communities in the field of nanomedicine
  2. Halamoda-Kenzaoui, Blanka; Baconnier, Simon; Bastogne, Thierry; Bazile, Didier; Boisseau, Patrick; Borchard, Gerrit; Borgos, Sven Even; Calzolai, Luigi; Cederbrant, Karin; Di Felice, Gabriella; Di Francesco, Tiziana; Dobrovolskaia,Marina; Gaspar, Rogério; Gracia, Belén; Hackley, Vincent A; Leyens, Lada; Liptrott, Neill; Park, Margriet; Patri, Anil; Roebben, Gert; Roesslein, Matthias; Thürmer, René; Urbán, Patricia; Zuang, Valérie; Bremer-Hoffmann, Susanne
  3. Regulatory toxicology and pharmacology : RTP. 2019, Aug; 106: 187-196.
  1. 16.   Measuring IRB Regulatory Compliance: Development, Testing, and Use of the National Cancer Institute StART Tool
  2. Rooney, Lisa; Covington, Laura; Dedier, Andrea; Samuel, Birdena
  3. JOURNAL OF EMPIRICAL RESEARCH ON HUMAN RESEARCH ETHICS. 2019, Apr; 14(2): 95-106.
  1. 17.   The mechanism of PI3K activation at the atomic level
  2. Zhang,Mingzhen; Jang,Hyunbum; Nussinov,Ruth
  3. Chemical science. 2019, Mar 28; 10(12): 3671-3680.
  1. 18.   Kaposi sarcoma
  2. Cesarman, Ethel; Damania, Blossom; Krown, Susan E.; Martin, Jeffrey; Bower, Mark; Whitby,Denise
  3. NATURE REVIEWS DISEASE PRIMERS. 2019, Jan 31; 5(1):
  1. 19.   Understanding the tumour micro-environment communication network from an NOS2/COX2 perspective
  2. Basudhar,Debashree; Bharadwaj, Gaurav; Somasundaram,Veena; Cheng,Robert; Ridnour,Lisa; Fujita, Mayumi; Lockett,Stephen; Anderson,Steve; McVicar,Daniel; Wink,David
  3. British Journal of Pharmacology. 2019, Jan; 176(2): 155-176.
  1. 20.   Calmodulin (CaM) Activates PI3K alpha by Targeting the "Soft" CaM-Binding Motifs in Both the nSH2 and cSH2 Domains of p85 alpha
  2. Zhang,Mingzhen; Li, Zhigang; Wang, Guanqiao; Jang,Hyunbum; Sacks, David B.; Zhang, Jian; Gaponenko, Vadim; Nussinov,Ruth
  3. JOURNAL OF PHYSICAL CHEMISTRY B. 2018, Dec 13; 122(49): 11137-11146.
  1. 21.   Nonhuman primate models of human viral infections
  2. Estes, Jake; Wong, Scott W.; Brenchley, Jason M.
  3. NATURE REVIEWS IMMUNOLOGY. 2018, Jun; 18(6): 390-404.
  1. 22.   Association ofTNFRSF1BPromoter Polymorphisms with Human Disease: Further Studies Examining T-Regulatory Cells Are Required
  2. Li, Hongchuan; Anderson, Steve
  3. Frontiers in immunology. 2018, Mar 6; 9: 443.
  1. 23.   Transcriptome Assessment of Erythema Migrans Skin Lesions in Patients with Early Lyme Disease Reveals Predominant Interferon Signaling
  2. Marques, Adriana; Schwartz, Ira; Wormser, Gary P; Wang, Yanmei; Hornung, Ronald L; Demirkale, Cumhur Y; Munson, Peter J; Turk, Siu-Ping; Williams, Carla; Lee, Chyi-Chia Richard; Yang, Jun; Petzke, Mary M
  3. Journal of Infectious Diseases. 2018, Jan 1; 217(1): 158-167.
  1. 24.   Equivalence of complex drug products: advances in and challenges for current regulatory frameworks.
  2. Hussaarts, Leonie; Mühlebach, Stefan; Shah, Vinod P; McNeil, Scott; Borchard, Gerrit; Flühmann, Beat; Weinstein, Vera; Neervannan, Sesha; Griffiths, Elwyn; Jiang, Wenlei; Wolff-Holz, Elena; Crommelin, Daan J A; de Vlieger, Jon S B
  3. Annals of the New York Academy of Sciences. 2017, Nov; 1407(1, SI): 39-49.
  1. 25.   CTLA-4(+)PD-1(-) Memory CD4(+) T Cells Critically Contribute to Viral Persistence in Antiretroviral Therapy-Suppressed, SIV-Infected Rhesus Macaques
  2. McGary, Colleen S; Deleage, Claire; Harper, Justin; Micci, Luca; Ribeiro, Susan P; Paganini, Sara; Kuri-Cervantes, Leticia; Benne, Clarisse; Ryan, Emily S; Balderas, Robert; Jean, Sherrie; Easley, Kirk; Marconi, Vincent; Silvestri, Guido; Estes, Jake; Sekaly, Rafick-Pierre; Paiardini, Mirko
  3. Immunity. 2017, Oct 17; 47(4): 776-788.e5.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel